Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

G-CYBERHEART

Financiado

Computationally and experimentallY BioEngineeRing the next generation of Growing...

Congenital Heart Disease (CHD) results when the heart abnormally develops before birth. With diminished cardiac function, the heart fails to supply the required oxygenated blood to the body, causing a cascade of failures at differ... ver más

31/08/2027

UPV

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

UNIVERSITAT POLITÈCNICA DE VALÈNCIA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 683

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-03-11

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2021-STG: ERC STARTING GRANTS

I+D

Cerrada hace 3 años

0% 100%

1 Participantes

UPV

1.50M€ | Lider

Proyectos interesantes

iPS-ChOp-AF Combining induced pluripotent stem cells tissue engineering... 2M€ Cerrado

3DCardiacHTS Bringing 3D cardiac tissues to high throughput for drug disc... 1M€ Cerrado

PLEC2021-008127 Biofabricación avanzada multifunción en 3D para la generació... 204K€ Cerrado

I3 Innovative Imaging Insights (I3): Development of MR-compatib... 174K€ Cerrado

CARDINAL CARdiac tissue Design, beating INduction, and Assessment usi... 173K€ Cerrado

DISSECT-HF Dynamic engIneered heart tiSsue to Study intEr-individual su... 2M€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 65 meses Fecha Inicio: 2022-03-11
Fecha Fin: 2027-08-31

Líder del proyecto

UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Total investigadores 683

Presupuesto del proyecto 1M€

Descripción del proyecto Congenital Heart Disease (CHD) results when the heart abnormally develops before birth. With diminished cardiac function, the heart fails to supply the required oxygenated blood to the body, causing a cascade of failures at different scales that prevent the newborn from growing normally. Even with improved surgical and medical treatments, CHD remains a lifelong risk factor for many diseases. An emerging application in cardiac tissue engineering is the 3D bioprinting of human hearts, or their parts, for clinical transplantation, with CHD representing a potential therapeutic target. Whereas the fabrication of bioartificial hearts is currently feasible, there remain significant scientific and technological challenges that yet need to be overcome. The development of novel experimental approaches is fundamental. At the same time, there is a pressing need for complementary computational methods to efficiently assist in the design of biophysically feasible and printable hearts, which must necessarily grow with the CHD patient's body while adapting to lifelong changes in hemodynamic conditions. In this project, therefore, I will develop a highly novel and interrelated experimental and computational approach for reproducing and predicting growing conditions of bioengineered hearts. The ambitious experimental design will enhance the maturation of cardiac muscle and biomechanical function of bioprinted ventricles in dynamic bioreactors. The highly-coupled multi-physics computational platform will describe these complex processes under multiple stimulated conditions to, ultimately, predict the critical adaptation and evolution of bioengineered ventricles potentially implanted in CHD patients. Therefore, by integrating ground-breaking methods within an extremely complex scenario, G-CYBERHEART will cross boundaries to drive advances in regenerative medicine and tissue engineering that will help accelerate the development of the bioengineered heart of the future.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores